InMed Pharmaceuticals (INM) Enterprise Value (2020 - 2026)
InMed Pharmaceuticals (INM) posted quarterly Enterprise Value of -$5.2 million for Q1 2026, down 10.57% year-over-year from -$5.9 million in Q1 2025, and up 25.57% quarter-over-quarter from -$7.0 million in Q4 2025.
InMed Pharmaceuticals (INM) Enterprise Value (2020 - 2026) Analysis & Trends
InMed Pharmaceuticals' Enterprise Value history runs 7 years deep, the most recent figure standing at -$5.2 million for Q1 2026.
- In Q1 2026, Enterprise Value fell 10.57% year-over-year to -$5.2 million; the TTM figure through Mar 2026 stood at -$5.2 million (down 10.57% YoY), while the FY2025 annual figure was -$10.8 million, down 63.07% from the prior year.
- Enterprise Value for Q1 2026 stood at -$5.2 million, up from -$7.0 million in the prior quarter.
- The five-year high for Enterprise Value was -$1.3 million in Q3 2024, with the low at -$11.5 million in Q4 2022.
- The 5-year median for Enterprise Value is -$6.6 million (2024), against an average of -$6.8 million.
- The sharpest annual moves came in 2023 and 2025: Enterprise Value surged 88.23% in 2023, then sank 632.31% in 2025.
- InMed Pharmaceuticals' Enterprise Value stood at -$11.5 million in 2022, then soared by 88.23% to -$1.4 million in 2023, then plunged by 224.37% to -$4.4 million in 2024, then slumped by 60.54% to -$7.0 million in 2025, then advanced by 25.57% to -$5.2 million in 2026.
- Business Quant data shows INM's Enterprise Value at -$5.2 million in Q1 2026, -$7.0 million in Q4 2025, and -$9.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | -164.00 Mn |
| 10 | InMed Pharmaceuticals | 6.36 Mn | 1.11 Mn | - | -5.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.24 Mn |
| Dec 31, 2025 | -7.04 Mn |
| Sep 30, 2025 | -9.37 Mn |
| Jun 30, 2025 | -10.79 Mn |
| Mar 31, 2025 | -4.74 Mn |
| Dec 31, 2024 | -4.39 Mn |
| Sep 30, 2024 | -1.28 Mn |
| Jun 30, 2024 | -6.61 Mn |
| Mar 31, 2024 | -6.62 Mn |
| Dec 31, 2023 | -1.35 Mn |
| Sep 30, 2023 | -6.78 Mn |
| Jun 30, 2023 | -8.96 Mn |
| Mar 31, 2023 | -9.64 Mn |
| Dec 31, 2022 | -11.50 Mn |
| Sep 30, 2022 | -9.39 Mn |
| Jun 30, 2022 | -6.22 Mn |
| Mar 31, 2022 | -5.95 Mn |
| Dec 31, 2021 | -11.35 Mn |
| Sep 30, 2021 | -15.35 Mn |
| Jun 30, 2021 | -7.41 Mn |